Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Finuservices launched a showcase with investment coins

12/25/24 MOEX

Astra updated its dividend policy

12/25/24 ASTR

Gazprom expects more than ₽2.8 trillion EBITDA by 2024 results

12/24/24 GAZP

Gazprom's Board of Directors approved the investment program for 2025

12/24/24 GAZP

Ozone Pharmaceuticals has already shipped more than 1 million packs of the drug Cruoxaban

12/24/24 OZPH

Polyus' Board of Directors proposed a share split

12/24/24 PLZL

Fix Price has registered a Russian legal entity

12/24/24 FIXP

Trading in shares of "Corporate Center X 5" will begin on January 9

12/24/24 X5

Nizhnekamskneftekhim completed construction of EP-600

12/24/24 NKNC

MTS subsidiary will be given 10 billion rubles to create mobile base stations

12/24/24 MTSS